Preliminary results from a large clinical trial comparing digital to conventional film mammography are in: While both methods can detect breast cancer equally well in the general population, digital mammography is better suited for women younger than 50 years, those who are pre- or perimenopausal (i.e., have had a menstrual period within the last 12 months), and those with dense breasts—a population at higher risk for breast cancer.
Preliminary results from a large clinical trial comparing digital to conventional film mammography are in: While both methods can detect breast cancer equally well in the general population, digital mammography is better suited for women younger than 50 years, those who are pre- or perimenopausal (i.e., have had a menstrual period within the last 12 months), and those with dense breasts-a population at higher risk for breast cancer.
Researchers provided both digital and film mammography to almost 50,000 asymptomatic women at 33 sites in the United States and Canada. While the diagnostic accuracy of the two methods in the entire population was similar, the accuracy of digital mammography was significantly higher than that of film mammography in women younger than 50 years, women with heterogeneously dense or extremely dense breasts on mammography, and pre- or perimenopausal women.
Digital mammography provides the additional advantages of easier access to and transmission, retrieval, and storage of images; it also uses a lower average dose of radiation. Issues of cost-effectiveness and effect on patient quality-of-life via a reduction in false-positive results will be assessed and reported at a later date.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More